Managed Health Care launches new home infusion pharmacy

Managed Health Care Associates (MHA), a healthcare services and software company in Chicago, has released its new Home Infusion Pharmacy, which will help home infusion pharmacy customers compete in a value-based reimbursement market.

MHS partnered with Strategic Healthcare Programs (SHP), a data analytics provider based in Barbara, California, to develop the system, which provides access to benchmarking and real-time data to help treat patients. It responds to growing patient populations and alternate payment models.

"SHP is recognized as the absolute leader in the home health and hospice benchmarking and data analytics space, and this new home infusion solution will contain the same type of industry leading analytics,” said MHA President Michael J. Sicilian in a statement. “As the industry evolves in the new quality based reimbursement environment, home infusion providers are going to need very unique and detailed data to demonstrate their value. This new product will be an important component in showing that value.”

The product will be able to capture daily trends and insights from clinical, financial, demographic and utilization data.

"We are confident that these new reports and analytics will help Home Infusion providers to more effectively use their data to improve performance just as our other solutions do in the Home Health and Hospice markets,” said SHP President Rob Paulsson in a statement.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”